Alibaba Group Holding Limited
Citi Analyst Take
Citi's note (as cited by the report) spotlights Alibaba Cloud's AI opportunity and positions the business as a "China's Alphabet Inc
The analyst maintains a 'Buy' rating with an Alibaba ADR price forecast of $205. The analyst reiterated it as the 'Top Pick for AI Investment in China'.
Technical Analysis
From a trend perspective, BABA is trying to build a base above its shorter-term averages, trading 0.6% above the 20-day SMA ($135.31) and 3.4% above the 50-day SMA ($131.64). The bigger issue is overhead supply: the stock is still trading 6.2% below the 100-day SMA ($145.12) and 8.5% below the 200-day SMA ($148.76), which keeps the longer-term trend repair incomplete.
Momentum looks more "range-bound than stretched," with the RSI at 54.58, a neutral reading that often aligns with consolidation rather than a breakout or breakdown. In other words, RSI measures how extended the recent move is, and this level suggests buyers and sellers are relatively balanced right now.
The moving-average structure is mixed: the 20-day SMA is above the 50-day SMA (a near-term bullish tilt), but the death cross from April (when the 50-day SMA fell below the 200-day SMA) still hangs over the chart as a longer-term caution flag. That combination often produces choppy trading, where rallies can work but tend to run into resistance until the price can reclaim the longer-term averages.
- Key Resistance: $139.00 - a nearby round-number area where rebounds can stall, especially with price still below longer-term averages
- Key Support: $129.00 - a nearby level where buyers previously stepped in, and a break would put focus back on the April swing-low zone.
Alibaba Group is set to report earnings on May 13, 2026 (confirmed).
- EPS Estimate: $1.12 (Down from $1.73 YoY)
- Revenue Estimate: $35.23 Billion (Up from $32.58 Billion YoY)
- Valuation: P/E of 24.1x (Suggests fair valuation relative to peers)
- Barclays: Overweight (Lowers Forecast to $186.00) (April 14)
- Susquehanna: Positive (Lowers Forecast to $170.00) (March 26)
- JP Morgan: Overweight (Lowers Forecast to $205.00) (March 20)
